A role for dopamine D2 receptors in reversal learning

Autor: DeSteno, D.A., Schmauss, C.

Publikováno v: In Neuroscience 2009 162(1):118-127

targeted disruption of the dopamine D 2 and D 3 receptor genes leads to different alterations in the expression of striatal Calbindin-D 28k

Autor: Jung, M.-Y ^*, Hof, P.R ^†, Schmauss, C ^{*, *}

Publikováno v: In Neuroscience 2000 97(3):495-504

Blockade of dopamine D3 receptors improves hippocampal synaptic function and rescues age‐related cognitive phenotype.

Autor: Tropea, Maria Rosaria¹ (AUTHOR), Melone, Marcello^2,3 (AUTHOR), Li Puma, Domenica Donatella^4,5 (AUTHOR), Vacanti, Valeria¹ (AUTHOR), Aceto, Giuseppe^4,5 (AUTHOR), Bandiera, Bruno⁴ (AUTHOR), Trovato, Roberta Carmela¹ (AUTHOR), Torrisi, Sebastiano Alfio¹ (AUTHOR), Leggio, Gian Marco¹ (AUTHOR), Palmeri, Agostino¹ (AUTHOR), D'Ascenzo, Marcello^4,5 (AUTHOR), Conti, Fiorenzo^2,3 (AUTHOR), Grassi, Claudio^4,5 (AUTHOR), Puzzo, Daniela^1,6 (AUTHOR) danypuzzo@yahoo.it

Publikováno v: Aging Cell. Nov2024, Vol. 23 Issue 11, p1-16. 16p.

New roles for dopamine D 2 and D 3 receptors in pancreatic beta cell insulin secretion.

Autor: Farino ZJ; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Morgenstern TJ; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Maffei A; Division of Endocrinology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Quick M; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA., De Solis AJ; Division of Molecular Genetics, Naomi Berrie Diabetes Center, Columbia University, New York, NY, USA., Wiriyasermkul P; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Freyberg RJ; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Aslanoglou D; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Sorisio D; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Inbar BP; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Free RB; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Donthamsetti P; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Mosharov EV; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Department of Neurology, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Kellendonk C; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Department of Pharmacology, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Schwartz GJ; Departments of Medicine and Neuroscience, Albert Einstein College of Medicine, Bronx, NY, USA., Sibley DR; Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Schmauss C; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA., Zeltser LM; Division of Molecular Genetics, Naomi Berrie Diabetes Center, Columbia University, New York, NY, USA.; Department of Pathology and Cell Biology, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Moore H; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Integrative Neuroscience, New York State Psychiatric Institute, New York, NY, USA., Harris PE; Division of Endocrinology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Javitch JA; Department of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.; Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.; Department of Pharmacology, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA., Freyberg Z; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA. freyberg@pitt.edu.; Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA, USA. freyberg@pitt.edu.

Publikováno v: Molecular psychiatry [Mol Psychiatry] 2020 Sep; Vol. 25 (9), pp. 2070-2085. Date of Electronic Publication: 2019 Jan 09.

New Role of the Serotonin as a Biomarker of Gut–Brain Interaction.

Autor: Liu, Hong Nian¹ (AUTHOR) konen@med.nagoya-u.ac.jp, Nakamura, Masanao¹ (AUTHOR), Kawashima, Hiroki¹ (AUTHOR)

Publikováno v: Life (2075-1729). Oct2024, Vol. 14 Issue 10, p1280. 16p.